ReviewFrontiers in immunology2025

TWEAK-Fn14: a promising target for cardio-cerebrovascular diseases and brain-heart syndrome.

Qinglin Fei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.